Eyevensys Raises $12M in a Series B Plus Funding Round
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #Eyevensys--Eyevensys, a private biotech developing gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.